Martin Sedlacek, M.D. Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Lebanon, NH 03756 Phone: 603-653-3830 Fax: 603-650-0924 |
Brian David Remillard, MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Dartmouth-hitchcock Clinic, Lebanon, NH 03756 Phone: 603-653-3830 |
Elizabeth Jane Brant, M.D. Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Lebanon, NH 03756 Phone: 603-653-3830 |
Dr. Anton C Schoolwerth, M.D. Internal Medicine - Nephrology Medicare: Not Enrolled in Medicare Practice Location: 1 Medical Center Dr, Dhmc, Department Of Medicine, Lebanon, NH 03756 Phone: 603-653-3830 |
Dr. Michael Charles Chobanian, M.D. Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Lebanon, NH 03756 Phone: 603-653-3931 Fax: 603-650-0924 |
Dr. Martha Graber, Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Lebanon, NH 03756 Phone: 603-650-3830 |
Fariha Chaudhry, MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: One Medical Center Drive, Dartmouth Hitchcock Medical Center, Lebanon, NH 03756 Phone: 603-650-5000 |
Thomas Masao Kaneko, MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Section Of Hypertension, Lebanon, NH 03756 Phone: 603-653-3830 Fax: 603-650-0924 |
Dr. Clay A. Block, M.D. Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Lebanon, NH 03756 Phone: 603-653-3830 Fax: 603-653-3991 |
News Archive
A new study reports that a loss of genes on chromosome 1 or chromosome 11 raises the risk of death from the children's cancer neuroblastoma, even when other indicators seem to point to a lower-risk form of the disease.
Researchers at Memorial Sloan Kettering Cancer Center in New York City and Massachusetts Institute of Technology in Boston have developed a new, three-step system that uses nuclear medicine to target and eliminate colorectal cancer.
Merck & Co., Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved ZEGERID OTC(TM) (omeprazole 20 mg/sodium bicarbonate 1100 mg capsules), for over-the-counter treatment of frequent heartburn.
In what is thought to be a world-first, a British woman who was given an ovary transplant is about to give birth to her first baby.
› Verified 5 days ago